CompletedNot Applicable

Diagnostic Consistency of GLIM and PG-SGA for Malnutrition in Pancreatic Cancer

China108 participantsStarted 2023-01-01

Plain-language summary

This study aimed to evaluate the diagnostic consistency between the Global Leadership Initiative on Malnutrition (GLIM) criteria and the Patient-Generated Subjective Global Assessment (PG-SGA) for identifying malnutrition in patients with pancreatic malignant tumors. The goal is to determine if the GLIM criteria, a newer and more streamlined tool, shows substantial agreement with the well-established PG-SGA, thereby supporting its use in this high-risk clinical population.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Histopathologically confirmed pancreatic malignant tumor. * Age ≥ 18 years. * Clear cognition and ability to communicate verbally. * Nutritional Risk Screening 2002 (NRS 2002) score ≥ 3. * Provision of written informed consent to participate. Exclusion Criteria: * Presence of severe cardiac, hepatic, or renal comorbidities. * Bedridden status precluding weight measurement. * Contraindications to bioelectrical impedance analysis (e.g., implanted electronic devices, amputation). * Concurrent diagnosis of other malignant tumors, particularly of the digestive system. * Inability to cooperate with questionnaire completion or assessments.

What they're measuring

Diagnostic Consistency between GLIM Criteria and PG-SGA

Timeframe: Assessed once within 24 hours of hospital admission.

Trial details

NCT IDNCT07057895

SponsorThe First Hospital of Hebei Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Pancreatic Neoplasms trials